Qaialdo® 10 mg/ml

Qaialdo® (spironolactone 10 mg/ml oral suspension) is the first liquid dosage form of the aldosterone antagonist spironolactone to become available. The formulation, which has been approved by the European Medicines Agency (EMA), enables precise, age- and weight-specific dosing from infancy onwards.

Learn more about Qaialdo®

For detailed information about Xaluprine®, please visit our official website: www.qaialdo.de